ROSA MARÍA
AYALA DÍAZ
Profesora asociada de Ciencias de la Salud
Universidad Politécnica de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Politécnica de Madrid (5)
2023
-
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681
-
Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma (Journal of Hematology & Oncology, (2023), 16, 1, (76), 10.1186/s13045-023-01474-w)
Journal of Hematology and Oncology
-
Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
Journal of Hematology and Oncology
2022
-
Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network
Blood Cancer Journal, Vol. 12, Núm. 6
2021
-
Impact of COVID-19 in patients with multiple myeloma based on a global data network
Blood Cancer Journal, Vol. 11, Núm. 12